Publication at Third Faculty of Medicine, Faculty of Physical Education and Sport |
2022
Abstract
Chronic heart failure is a disease exhibiting high mortality and morbidity and leading to a significant deterioration in the patients' quality of life. Our treatment of patients suffering from this disease aims to improve their clinical condition while reducing their mortality and frequency of hospitalizations for heart failure.
In recent years a considerable progress has been made in the treatment of patients with chronic heart failure, which has led to improvements in the above factors. This article offers a brief summary of the pharmacotherapy of chronic heart failure as it was published in the new 2021 guidelines of the European Society of Cardiology.